WO2011141685A3 - Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof - Google Patents
Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof Download PDFInfo
- Publication number
- WO2011141685A3 WO2011141685A3 PCT/FR2011/051082 FR2011051082W WO2011141685A3 WO 2011141685 A3 WO2011141685 A3 WO 2011141685A3 FR 2011051082 W FR2011051082 W FR 2011051082W WO 2011141685 A3 WO2011141685 A3 WO 2011141685A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- constituents
- nasal compositions
- cocoyl proline
- systemic nasal
- cocoyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Abstract
The invention relates to a pharmaceutical composition that can be administered nasally, comprising cocoyl proline or at least one of its constituents and a therapeutic agent. The invention also relates to the production method thereof and uses of same.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1002068A FR2959936B1 (en) | 2010-05-14 | 2010-05-14 | NASAL COMPOSITION WITH A SYSTEMIC VIEW BASED ON COCOYL PROLINE OR AT LEAST ONE OF ITS COMPONENTS |
FR10/02068 | 2010-05-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011141685A2 WO2011141685A2 (en) | 2011-11-17 |
WO2011141685A3 true WO2011141685A3 (en) | 2012-08-02 |
Family
ID=43413662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2011/051082 WO2011141685A2 (en) | 2010-05-14 | 2011-05-13 | Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2959936B1 (en) |
WO (1) | WO2011141685A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014023959B1 (en) * | 2012-03-30 | 2020-10-20 | Givaudan Sa | edible composition |
CA2867300C (en) * | 2012-03-30 | 2019-08-20 | Givaudan S.A. | N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds |
BR112014023905B1 (en) | 2012-03-30 | 2021-07-13 | Givaudan Sa | FLAVOR AND EDIBLE COMPOSITIONS INCLUDING N-ACYLATE METHIONINE DERIVATIVES AND CALORIC AND NON-CALORIC BEVERAGE |
SG11201405409PA (en) | 2012-03-30 | 2014-11-27 | Givaudan Sa | N-acylated 1 - aminocycloalkyl carboxylic acids as food flavouring compounds |
WO2013149031A2 (en) * | 2012-03-30 | 2013-10-03 | Givaudan S.A. | Powder flavour composition |
JP6248091B2 (en) | 2012-03-30 | 2017-12-13 | ジボダン エス エー | N-acyl derivatives of gamma aminobutyric acid and beta alanine as food flavoring compounds |
CN106220546B (en) * | 2012-03-30 | 2018-11-30 | 奇华顿股份有限公司 | N- acyl-proline derivative as food fragrance compound |
US10834943B2 (en) | 2013-10-02 | 2020-11-17 | Givaudan S.A. | Organic compounds having taste-modifying properties |
WO2015050535A1 (en) | 2013-10-02 | 2015-04-09 | Givaudan S.A. | Organic compounds |
GB201317424D0 (en) | 2013-10-02 | 2013-11-13 | Givaudan Sa | Improvements in or relating to organic compounds |
EP3057444B1 (en) | 2013-10-02 | 2017-12-06 | Givaudan SA | Organic compounds having taste-modifying properties |
EP3057447B1 (en) | 2013-10-02 | 2017-12-06 | Givaudan S.A. | Organic compounds having taste-modifying properties |
CN105636934B (en) | 2013-10-02 | 2019-03-29 | 奇华顿股份有限公司 | N- acylated 2- aminoisobutyric acid compound and the perfume compositions comprising them |
EP3057446B1 (en) | 2013-10-02 | 2017-12-06 | Givaudan S.A. | Organic compounds having taste-modifying properties |
US10674755B2 (en) | 2013-10-02 | 2020-06-09 | Givaudan S.A. | Organic Compounds |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4837026A (en) * | 1985-10-03 | 1989-06-06 | Rajakhyaksha Vithal J | Transdermal and systemic preparation and method |
FR2686511A1 (en) * | 1992-01-28 | 1993-07-30 | Ir2M | Pharmaceutical composition containing combinations of vanadium and/or niobium with amino acids or amino acid derivatives |
WO2002076506A1 (en) * | 2001-03-28 | 2002-10-03 | Physica S.A.R.L. | Use of lipoaminoacids as absorption promoters in a pharmaceutical composition |
FR2834215A1 (en) * | 2001-12-27 | 2003-07-04 | Physica | AMPHIPHILIC COMPOUNDS FOR PHARMACEUTICAL OR COSMETIC USE |
US20040248846A1 (en) * | 2003-04-22 | 2004-12-09 | Nastech Pharmaceutical Company Inc. | Intranasal administration of triptans |
FR2935378A1 (en) * | 2008-08-29 | 2010-03-05 | Seppic Sa | USE OF N-ACYL AMINO ACIDS AS COSMETIC AND PHARMACEUTICAL ACTIVE INGREDIENTS CAPABLE OF REDUCING THE INFLAMMATORY CONDITION OF SENESCENT REPLICATIVE FIBROBLASTS FROM HUMAN ADULT DERMAS; ANTI-AGE COSMETIC COMPOSITIONS |
WO2010029374A1 (en) * | 2008-09-12 | 2010-03-18 | Critical Pharmaceuticals Limited | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
-
2010
- 2010-05-14 FR FR1002068A patent/FR2959936B1/en not_active Expired - Fee Related
-
2011
- 2011-05-13 WO PCT/FR2011/051082 patent/WO2011141685A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4837026A (en) * | 1985-10-03 | 1989-06-06 | Rajakhyaksha Vithal J | Transdermal and systemic preparation and method |
FR2686511A1 (en) * | 1992-01-28 | 1993-07-30 | Ir2M | Pharmaceutical composition containing combinations of vanadium and/or niobium with amino acids or amino acid derivatives |
WO2002076506A1 (en) * | 2001-03-28 | 2002-10-03 | Physica S.A.R.L. | Use of lipoaminoacids as absorption promoters in a pharmaceutical composition |
FR2834215A1 (en) * | 2001-12-27 | 2003-07-04 | Physica | AMPHIPHILIC COMPOUNDS FOR PHARMACEUTICAL OR COSMETIC USE |
US20040248846A1 (en) * | 2003-04-22 | 2004-12-09 | Nastech Pharmaceutical Company Inc. | Intranasal administration of triptans |
FR2935378A1 (en) * | 2008-08-29 | 2010-03-05 | Seppic Sa | USE OF N-ACYL AMINO ACIDS AS COSMETIC AND PHARMACEUTICAL ACTIVE INGREDIENTS CAPABLE OF REDUCING THE INFLAMMATORY CONDITION OF SENESCENT REPLICATIVE FIBROBLASTS FROM HUMAN ADULT DERMAS; ANTI-AGE COSMETIC COMPOSITIONS |
WO2010029374A1 (en) * | 2008-09-12 | 2010-03-18 | Critical Pharmaceuticals Limited | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
Also Published As
Publication number | Publication date |
---|---|
WO2011141685A2 (en) | 2011-11-17 |
FR2959936B1 (en) | 2012-08-03 |
FR2959936A1 (en) | 2011-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011141685A3 (en) | Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof | |
IL275854A (en) | Pharmaceutical composition and administration thereof | |
IL233677A (en) | Substituted benzisoxazole aminopyrazolo-pyrimidine compounds, pharmaceutical compositions comprising them and use of the compounds for the manufacture of medicaments | |
WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
WO2011103202A3 (en) | Androgen receptor modulators and uses thereof | |
WO2012037410A3 (en) | Estrogen receptor modulators and uses thereof | |
WO2011156518A3 (en) | Estrogen receptor modulators and uses thereof | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
WO2010039977A3 (en) | Heteroaryl antagonists of prostaglandin d2 receptors | |
WO2012174158A3 (en) | Administration of benzodiazepine | |
WO2010037059A3 (en) | Heteroaryl antagonists of prostaglandin d2 receptors | |
WO2011060049A3 (en) | Spiro-oxindole mdm2 antagonists | |
WO2008132229A3 (en) | Highly concentrated insulin solutions and compositions | |
WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
WO2012075383A3 (en) | Bromodomain inhibitors and uses thereof | |
WO2011086093A3 (en) | Pharmaceutical compositions for oral administration of insulin peptides | |
ZA201008379B (en) | Glucocorticoid mimetics,methods of making them,pharmaceutical compositions,and uses thereof | |
UA98839C2 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors | |
WO2009108720A3 (en) | Antagonists of prostaglandin d2 receptors | |
WO2010057118A3 (en) | Heterocyclic antagonists of prostaglandin d2 receptors | |
WO2012021715A3 (en) | Stable formulations of linaclotide | |
WO2007125105A3 (en) | Benzamide glucokinase activators | |
IL211842A (en) | Antibody or human tgfbrii-binding fragment thereof, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for inhibiting angiogenesis | |
EP2431366A4 (en) | New chlorine e6-folic acid conjugated compound, preparation method thereof, and pharmaceutical composition containing the same for treatment of cancer | |
WO2010085820A3 (en) | Tricyclic compounds as antagonists of prostaglandin d2 receptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11725487 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11725487 Country of ref document: EP Kind code of ref document: A2 |